Clinical Trials Tech

eClinical platforms manage electronic data capture, randomization, and trial supply. Decentralized trial technology enables telemedicine visits, home health visits, and remote monitoring for trial participants. AI trial design uses historical data to optimize endpoints, sample size, and inclusion criteria. Patient matching algorithms connect eligible patients with relevant trials.

Decentralized trials enable patients to participate from home through wearable sensors and telemedicine visits. AI identifies optimal patient populations and predicts enrollment rates. Electronic consent and ePRO platforms reduce site burden. Real-world evidence supplements traditional trial data for regulatory submissions.

Clinical trials technology modernizes the $50+ billion annual global clinical research spend. With 3 funders. The average Phase III trial costs $150-200 million and takes 3-5 years, with 80% failing to meet enrollment timelines.